This statistic shows the number of new chemical or biological entities bought to the pharmaceutical industry in periods between 1998 and 2018, by region. In the period between 1998 and 2002, 29 new substances were introduced through Japanese companies.
Pharmaceutical industry - number of new substances 1992-2018
Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Availability of new medicines in selected countries 2013
- Direct export value of biological product from Taiwan 2008-2018
- Small molecules facing loss of developed market exclusivity 2011-2020
- New medicine availability by therapy area in the U.S. 2013
- Pharmaceutical Industry: Origin of new molecular entities
- Production value of biological product in Taiwan 2008-2018
- Domestic sales value of biological product in Taiwan 2008-2018
- Top new orphan molecular entities by U.S. sales in 2019
- U.S. biological products ad spend 2010-2016
- Italy: turnover of chemical and pharmaceutical bio-based products 2015-2016
- Number of new psychoactive substance identified globally 2014
- Domestic demand of surface-active agents Japan 2012-2018
- Number of oncology NMEs launched by biologics and non-biologic 2004-2013
- Medication: availability of anti-migraine active ingredients globally 2011
- Muslim groups and spaces in Spain in 2018, by type
- Sales value of biological product in Taiwan 2008-2018
- Phytosanitary treatments in arboriculture in France 2015, by type of fruit
- U.S. biological products: ad spend to sales ratio 2011-2015
- Industry revenue of “Biological preparations“ in Japan 2011-2023
- Forecast: value of shipments biological product manufacture US 2008-2020
Further related statistics
EFPIA. (June 20, 2019). Number of new chemical or biological entities developed between 1992 and 2018, by region of origin [Graph]. In Statista. Retrieved December 10, 2019, from https://www.statista.com/statistics/275262/pharmaceutical-industry-new-entities-by-region/
EFPIA. "Number of new chemical or biological entities developed between 1992 and 2018, by region of origin." Chart. June 20, 2019. Statista. Accessed December 10, 2019. https://www.statista.com/statistics/275262/pharmaceutical-industry-new-entities-by-region/
EFPIA. (2019). Number of new chemical or biological entities developed between 1992 and 2018, by region of origin. Statista. Statista Inc.. Accessed: December 10, 2019. https://www.statista.com/statistics/275262/pharmaceutical-industry-new-entities-by-region/
EFPIA. "Number of New Chemical or Biological Entities Developed between 1992 and 2018, by Region of Origin." Statista, Statista Inc., 20 Jun 2019, https://www.statista.com/statistics/275262/pharmaceutical-industry-new-entities-by-region/
EFPIA, Number of new chemical or biological entities developed between 1992 and 2018, by region of origin Statista, https://www.statista.com/statistics/275262/pharmaceutical-industry-new-entities-by-region/ (last visited December 10, 2019)